4-Cyclopropoxy-2-isopropylpyridine

Catalog No.: 
ACWVQQ699
CAS No.: 
1243345-07-4
Molecular Formula: 
C11H15NO
Molecular Weight: 
177.25
4-Cyclopropoxy-2-isopropylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Cyclopropoxy-2-isopropylpyridine
IUPAC Name4-cyclopropoxy-2-isopropylpyridine
Molecular FormulaC11H15NO
Molecular Weight177.25
SMILESCC(C1=NC=CC(OC2CC2)=C1)C
InChI KeyUQULVFUMNCUINP-UHFFFAOYSA-N
SynonymPyridine, 4-(cyclopropyloxy)-2-(1-methylethyl)-
CAS No.1243345-07-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWVQQ699 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFJPN518 route compound structure diagram
    ACFJPN51898420-91-8In Stock
  2. Plus
  3. ACBAOJ704 route compound structure diagram
    ACBAOJ70416545-68-9In Stock
  4. Then
  5. ACWVQQ699 route product structure diagram
    ACWVQQ6991243345-07-4
Inquiry

2. ACWVQQ699 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZQMO175 route compound structure diagram
    ACZQMO175908267-63-0In Stock
  2. Plus
  3. ACBAOJ704 route compound structure diagram
    ACBAOJ70416545-68-9In Stock
  4. Then
  5. ACWVQQ699 route product structure diagram
    ACWVQQ6991243345-07-4
Inquiry

3. ACWVQQ699 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBAOJ704 route compound structure diagram
    ACBAOJ70416545-68-9In Stock
  4. Then
  5. ACWVQQ699 route product structure diagram
    ACWVQQ6991243345-07-4
Inquiry

Comments (0)